Cheaper imported prescription drugs should not come at the expense of safety, said a U.S. government report issued on Tuesday that highlighted the problems of ensuring the medicines are equivalent to those purchased in the United States.

Congress required the Health and Human Services Department to conduct the study under last year’s new Medicare modernization law to see if a federal system could safely import medicines.